Nom du produit:4-Chloro-2-iodo-1-nitrobenzene
IUPAC Name:4-chloro-2-iodo-1-nitrobenzene
- CAS：160938-18-1
- Formule moléculaire：C6H3ClINO2
- Pureté：95%
- Numéro de catalogue：CM249918
- Poids moléculaire：283.45
Pour une utilisation en R&D uniquement..
Détails du produit
- N° CAS:160938-18-1
- Formule moléculaire:C6H3ClINO2
- Point de fusion:-
- Code SMILES:O=[N+](C1=CC=C(Cl)C=C1I)[O-]
- Densité:
- Numéro de catalogue:CM249918
- Poids moléculaire:283.45
- Point d'ébullition:309.263°C at 760 mmHg
- N° Mdl:MFCD11007732
- Stockage:Keep in dark place, store at room temperature.
Category Infos
- Benzenes
- Benzene is an important organic compound with the chemical formula C6H6, and its molecule consists of a ring of 6 carbon atoms, each with 1 hydrogen atom. Benzene is a sweet, flammable, colorless and transparent liquid with carcinogenic toxicity at room temperature, and has a strong aromatic odor. It is insoluble in water, easily soluble in organic solvents, and can also be used as an organic solvent itself. The ring system of benzene is called benzene ring, and the structure after removing one hydrogen atom from the benzene ring is called phenyl. Benzene is one of the most important basic organic chemical raw materials. Many important chemical intermediates can be derived from benzene through substitution reaction, addition reaction and benzene ring cleavage reaction.
Column Infos
- Lanifibranor
- Recently, Inventiva announced positive results of its interim analysis of the Phase II, Proof-of-Concept clinical trial, LEGEND, evaluating lanifibranor in combination with empagliflozin in patients with MASH/NASH and poorly controlled Type 2 Diabetes (T2D). The study achieved the primary efficacy endpoint. Lanifibranor is an orally-available small molecule pan PPAR agonist with a -wellbalanced- activation of PPARα and PPARδ, and a partial activation of PPARγ. Lanifibranor acts to induce anti fibrotic, anti-inflammatory and beneficial vascular and metabolic changes in the body.
Recherche 
+86 21 5895 0110 
